Skip to main content
. 2020 Oct 19;3(10):e2020425. doi: 10.1001/jamanetworkopen.2020.20425

Figure 2. Disease-Free Survival and Overall Survival, According to Treatment Group, in 318 Patients With High-Risk Stage II Colon Cancer.

Figure 2.

FOLFOX4 indicates 5-fluorouracil, leucovorin, and oxaliplatin; XELOX, capecitabine and oxaliplatin.